This enduring dialogue between two expert faculty aims to improve HCPs knowledge of the current treatment landscape of OAB, as well as improve HCPs clinical skills related to optimizing the use of beta-3 adrenergic agonists for the management of OAB.As a result of this educational activity, learners should be better able to: 1. Review the current treatment landscape of overactive bladder (OAB); 2. Discuss the clinical significance of the latest efficacy and safety data for beta-3 adrenergic agonists for the treatment of OAB; and, 3. Outline evidence-based, patient-centered strategies to optimally use beta-3 adrenergic agonists for the treatment of patients with OAB. Downloadable slides and podcast are available for learners to assist in clinical practice.
- Provider:Answers in CME Inc. (AiCME)
- Activity Link: https://www.answersincme.com/XCQ
- Start Date: 2024-12-23 06:00:00
- End Date: 2024-12-23 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
- Commercial Support: Source: Sumitomo - Amount: 161978.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Competence, Learner Knowledge
- Provider Ship: Directly Provided
- Registration: Open to all